Pharmaceuticals

Artery Stenosis Drug Market to Reach $3.34 Billion by 2029 | Key Drivers and Future Outlook

July 9, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Growth Rate of the Artery Stenosis Drug Market?#_x000D_

In recent times, the market size for artery stenosis medication has seen significant growth. It is projected to increase from $2.47 billion in 2024 to approximately $2.63 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. This growth during the historical period can be credited to a higher number of cardiovascular disease cases, an expanding elderly population, a rising awareness on the importance of arterial health, an increased utilization of telemedicine in patient monitoring, and enhanced healthcare infrastructure._x000D_

_x000D_

#What Growth Rate Is Forecasted for the Artery Stenosis Drug Market by 2029?#_x000D_

In the coming years, the market for artery stenosis drugs is projected to experience robust expansion. By 2029, it’s forecasted to reach $3.34 billion, with a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth during the forecast period include rising obesity and diabetes rates, an increasing need for less invasive procedures, broader healthcare provisions in developing markets, heightened healthcare spending, and an escalating prevalence of diabetes and obesity. The forecast period is also expected to witness key trends such as the adoption of personalized medicine tactics, a surge in combination therapies, advances in diagnosis methods, amplified emphasis on preventive cardiology, and the inception of innovative drug delivery systems._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24151&type=smp_x000D_

_x000D_

#Which Key Companies Are Shaping the Future of the Artery Stenosis Drug Market?#_x000D_

Major companies operating in the artery stenosis drug market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Sanofi S.A., GSK plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Regeneron Pharmaceuticals Inc., Lupin Limited, Alnylam Pharmaceuticals._x000D_

_x000D_

#Which Factors Are Driving Demand in the Artery Stenosis Drug Industry?#_x000D_

The increase in diabetes and obesity cases is anticipated to fuel the growth of the artery stenosis drug market. Diabetes, a chronic disease where the body either doesn’t produce enough insulin or fails to utilize it properly, leads to high blood sugar levels. On the other hand, obesity results from an excess of body fat, increasing the chances of various health problems. These conditions are escalating due to the rise in sedentary lifestyles, which are linked to an absence of regular physical activity, desk-bound jobs, and computer-related leisure activities, all contributing to weight gain and insulin resistance. Arterial stenosis medications are required for diabetes and obesity, due to the fact that both health conditions cause plaque formation in arteries, hence raising the chances of heart attacks and strokes. The World Health Organization, a Switzerland-based UN agency, reported in March 2024 that 2.5 billion adults were overweight and 890 million were obese in 2022. Therefore, the escalating rates of diabetes and obesity are stimulating the growth of the artery stenosis drug market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24151&type=smp_x000D_

_x000D_

#How Is the Artery Stenosis Drug Market Segmented by Several Divisions?#_x000D_

The artery stenosis drug market covered in this report is segmented –_x000D_

_x000D_

1) By Drug Type: Antiplatelet Agents, Anticoagulants, Statins, Beta Blockers_x000D_

2) By Mechanism Of Action: Platelet Aggregation Inhibitors, Thrombin Inhibitors, HMG-CoA Reductase Inhibitors, Beta-Adrenergic Antagonists_x000D_

3) By Route Of Administration: Oral, Injectable, Transdermal_x000D_

4) By Patient Type: Adults, Geriatric, Pediatric_x000D_

_x000D_

Subsegments:_x000D_

1) By Antiplatelet Agents: Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dipyridamole_x000D_

2) By Anticoagulants: Warfarin, Heparin, Low Molecular Weight Heparins, Direct Oral Anticoagulants (DOACs)_x000D_

3) By Statins: Atorvastatin, Simvastatin, Rosuvastatin, Pravastatin, Lovastatin_x000D_

4) By Beta Blockers: Metoprolol, Atenolol, Propranolol, Carvedilol, Bisoprolol_x000D_

_x000D_

#What are the Emerging Market Trends Driving the Growth of the Artery Stenosis Drug Industry?#_x000D_

Prominent businesses in the artery stenosis medication market are concentrating on advancing therapeutical solutions like Bempedoic Acid to address the unfulfilled medical needs in the management of high cholesterol. Bempedoic Acid is a pioneering drug aimed at reducing LDL cholesterol in patients who can’t endure statins or need more lipid-lowering treatments. For instance, as of May 2022, Zydus Lifesciences Ltd, a pharmaceutical firm based in India, introduced Bemdac in India. This new oral therapy for high cholesterol, encapsulates Bempedoic Acid, a trailblazing drug intended to decrease LDL cholesterol in patients unable to bear statins or needing an extra lipid-lowering treatment. This launch aims to provide an improved treatment alternative that enhances cardiovascular outcomes by aiming at cholesterol synthesis in the liver, also reducing the muscle-related side effects frequently related to statins._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/artery-stenosis-drug-global-market-report_x000D_

_x000D_

#Which Regions Are Driving Growth in the Artery Stenosis Drug Market?#_x000D_

North America was the largest region in the artery stenosis drug market in 2024. The regions covered in the artery stenosis drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24151&type=smp_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the artery stenosis drug market, and how is it changing globally?_x000D_

2. Who are the major companies in the artery stenosis drug market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the artery stenosis drug market right now?_x000D_

4. Which products or customer segments are growing the most in the artery stenosis drug market?_x000D_

5. What factors are helping or slowing down the growth of the artery stenosis drug market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_